Operating Lease, Right-of-Use Asset of Pyxis Oncology, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pyxis Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Pyxis Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $11,637,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Pyxis Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,637,000 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $11,847,000 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $12,049,000 -$729,000 -5.7% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $12,242,000 -$700,000 -5.4% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q1 2024 $12,778,000 -$680,000 -5.1% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $12,942,000 -$660,000 -4.9% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $13,129,000 -$1,567,000 -11% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $13,283,000 -$1,720,000 -11% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $13,458,000 -$1,842,000 -12% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $13,602,000 +$13,370,000 +5763% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $14,696,000 +$14,308,000 +3688% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $15,003,000 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $15,300,000 01 Apr 2022 10-K 22 Mar 2023 2022 FY
Q4 2021 $232,000 -$604,000 -72% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $388,000 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q4 2020 $836,000 31 Dec 2020 10-K 29 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.